Algoritmos de tratamiento de la enfermedad de Crohn desde una experiencia local

Revista Médica Clínica Las Condes - Tập 29 - Trang 663-677 - 2018
Patricio Ibáñez1, Rodrigo Quera1, Jaime Lubascher1, Carolina Figueroa1, Gonzalo Pizarro1, Udo Kronberg2, Lilian Flores1, Daniela Simian3
1Departamento de Gastroenterología, Clínica Las Condes, Santiago, Chile
2Unidad de Coloproctología, Departamento de Cirugía, Clínica Las Condes, Santiago, Chile
3Subdirección de Investigación, Dirección Académica, Programa de Enfermedad Inflamatoria Intestinal, Clínica Las Condes, Santiago, Chile

Tài liệu tham khảo

Danese, 2017, Early intervention in Crohn's disease: towards disease modification trials, Gut, 66, 2179, 10.1136/gutjnl-2017-314519

Allen, 2017, Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis, Aliment Pharmacol Ther, 45, 1058, 10.1111/apt.13995

Rutgeerts, 1990, Predictability of the postoperative course of Crohn's disease, Gastroenterology, 99, 956, 10.1016/0016-5085(90)90613-6

Daperno, 2004, Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD, Gastrointest Endosc, 60, 505, 10.1016/S0016-5107(04)01878-4

Kelly, 2017, Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease, Inflamm Bowel Dis, 23, 1202, 10.1097/MIB.0000000000001126

Zittan, 2016, Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease, Inflamm Bowel Dis, 22, 623, 10.1097/MIB.0000000000000652

Peyrin-Biroulet, 2014, Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial, Gut, 63, 88, 10.1136/gutjnl-2013-304984

Estay, 2015, Ionizing radiation exposure in patients with inflammatory bowel disease: are we overexposing our patients?, J Dig Dis, 16, 83, 10.1111/1751-2980.12213

Leong, 2016, Smoking cessation improves Crohn's disease outcomes regardless of the use of anti-TNF or immunomodulatory, Evid Based Med, 21, 153, 10.1136/ebmed-2016-110465

Freeman, 2014, Natural history and long-term clinical course of Crohn's disease, World J Gastroenterol, 20, 31, 10.3748/wjg.v20.i1.31

Barrie, 2007, Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease, Inflamm Bowel Dis, 13, 1424, 10.1002/ibd.20196

Gecse, 2016, Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn's Disease-the Unmet Needs, J Crohns Colitis., 10, 758, 10.1093/ecco-jcc/jjw039

Wainstein, 2018, Stem Cell Therapy in Refractory Perineal Crohn's Disease: Long-term Follow-up, Colorectal Dis, 10.1111/codi.14002